1 Apr
2004

The Novo Nordisk strategy for patent sucess

With a coveted place at the top of the increasingly competitive anti-diabetestreatments market, Novo Nordisk is committed to the careful management ofits intellectual property rights in order to maintain its position. Two keymembers of the company’s IP team explain how they do it. By Joff Wild